Cite
HARVARD Citation
Uspenskaya‐Cadoz, O. et al. (n.d.). Design of a Phase 1/2 study of an AAV9‐based gene therapy for fronto‐temporal dementia patients with pathogenic GRN mutations (PROCLAIM trial). Alzheimer's & dementia. p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Uspenskaya‐Cadoz, O. et al. (n.d.). Design of a Phase 1/2 study of an AAV9‐based gene therapy for fronto‐temporal dementia patients with pathogenic GRN mutations (PROCLAIM trial). Alzheimer's & dementia. p. n/a. [Online].